Physician profile
Michael Scott Lindner
NPI 1649274309
$4,250.83
in general payments reported to CMS, 2019-2025
24 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $106 · 2021: $1,021 · 2022: $175 · 2023: $1,610 · 2024: $268 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285 · Travel and Lodging: $1,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,284.85 |
| Travel and Lodging | $1,259.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,998.63 | 2022-2025 | Exalt Model D, Captivator II, Overstitch Nxt Endoscopic Suturing System |
| Abbvie INC. | $743.40 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $226.60 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $221.79 | 2019-2021 | |
| Olympus America INC. | $160.00 | 2021 | |
| Ardelyx, INC. | $135.95 | 2025 | Ibsrela |
| Janssen Biotech, INC. | $126.34 | 2021 | |
| Ferring Pharmaceuticals INC. | $102.44 | 2019-2021 | |
| Redhill Biopharma INC. | $93.03 | 2020-2021 | |
| Pfizer INC. | $91.57 | 2019-2021 | |
| Shionogi INC | $54.90 | 2019 | |
| Celgene Corporation | $42.99 | 2021 | |
| Ethicon US, LLC | $41.13 | 2021 | |
| Allergan, INC. | $34.29 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $30.61 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $30.53 | 2021 | |
| Intercept Pharmaceuticals, INC. | $21.23 | 2022 | |
| Braintree Laboratories, INC. | $17.11 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.97 | 2022 | |
| Gilead Sciences, INC. | $14.37 | 2020 | |
| Amgen INC. | $13.98 | 2021 | |
| Alfasigma USA, INC. | $11.68 | 2020 | |
| Alexion Pharmaceuticals, INC. | $11.30 | 2021 | |
| Qol Medical, LLC | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lindner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.